Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients. - Wikidata - awgldk - TriplyDB

Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.

Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.

http://www.wikidata.org/entity/Q33556747

about

Genetics of cardiovascular and renal complications in diabetes Diabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China.Identified single-nucleotide polymorphisms and haplotypes at 16q22.1 increase diabetic nephropathy risk in Han Chinese population Association of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies.Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians Genetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.The association of genetic variants of type 2 diabetes with kidney function The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.Smoking as a risk factor for diabetic nephropathy: a meta-analysis.The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.Peroxisome proliferator-activated receptor γ Pro12Ala polymorphism decrease the risk of diabetic nephropathy in type 2 diabetes: a meta analysis.Comment on: Zhang et al. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies. Diabetes Care 2012;35:1388-1393.Arg913Gln of SLC12A3 gene promotes development and progression of end-stage renal disease in Chinese type 2 diabetes mellitus.Association analysis of PPARγ (p.Pro12Ala) polymorphism with type 2 diabetic retinopathy in patients from north India.PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies

P2860

Q26752749-70167E8D-0D39-4123-9DDD-5C45B0E32528 Q30883079-32AC5FE6-51F6-4B16-AB69-D6169FD16C3F Q34463264-72FF035F-57AC-42E7-81A1-2936E89D9F3B Q34885498-1FD5A591-4247-47BF-ADEF-22DE474FC11B Q35058771-F65FABEE-A19F-4330-893E-783B0412153F Q35174597-E9DFB829-7E03-40A9-A4C8-EB5C6A36948F Q35976372-A73CA8D2-ED99-4B54-B942-975D745E7B85 Q36239731-2A477FD5-CD84-4D9F-962A-8B8002B43CC8 Q36250613-A6E59B84-E71C-4554-8830-CC7EB783C11D Q36877238-96C301DC-9DD6-400B-8876-0E824C0B6057 Q38121659-E0582690-C61E-431B-ACD5-941C90415C55 Q38254887-89E58F67-B369-49D6-B1F7-531B241CEF0F Q38718018-25DBEA16-78BF-4120-B335-7C8619499410 Q40579516-0885BE17-D101-4B01-A02F-CB1651423120 Q42364753-8A91C14A-70D6-4120-9B8B-0DDF3669E76F Q42419517-15860AD4-7812-4441-89AA-BB09E5642736 Q44361832-8CEF0308-1B27-48F0-91FD-5A6E6752C81D Q51635073-1B0EEDC2-7938-4444-9AC9-133AE2EEECE0 Q57701985-89F4FF22-387A-4324-A9FD-F42F4EA8D096

P2860

Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.

http://www.wikidata.org/entity/Q33556747

description

2009 nî lūn-bûn

@nan

2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@ast

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@en

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@nl

type

label

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@ast

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@en

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@nl

prefLabel

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@ast

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@en

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@nl

P1433

Q33556747-A3D3DCA0-8A71-45BE-972F-DD536570B9A2

P1476

Q33556747-9AF263A2-5D31-4C49-B005-B03147194597

P2093

Q33556747-2CAD19F5-2E30-42F8-A99A-D808664FD796

Q33556747-72220C25-C3CC-4438-A9B5-9C40AE3F7D4D

Q33556747-72827FFC-B8B3-47FD-AB6D-D71BF51EDBD7

Q33556747-91ECDBD8-A5C4-49A6-9FA4-61B4279669C8

Q33556747-97E8CB69-0345-496B-9E2B-66DE53CCE67A

Q33556747-9B0919F4-2F41-4A5A-B82F-A496855EF90E

Q33556747-ACEE2DAA-E14E-4BE6-A79C-E9D823AEB2F6

Q33556747-C78BE4B3-855F-4BB3-9BA9-B65511BC8200

Q33556747-F2A09997-363B-4947-B90B-00345FD092B2

P2860

Q33556747-04616346-78DC-4718-B36A-58C8E8826564

Q33556747-067914A6-71BD-4E3E-9EAA-226D8AA49E08

Q33556747-0CD0D07D-8A95-4365-80C4-146BB7A2F412

Q33556747-0D9BB7AE-FBD8-4652-A854-BC359CD4C3E3

Q33556747-473FE5EC-B842-4FB2-A74D-1E283E9CE930

Q33556747-48E78AD0-ADB5-4045-9305-ABFBF4119096

Q33556747-4A9D1364-1892-426F-9F88-DCBCCA7ACA94

Q33556747-54C04E53-7432-4B92-8006-A955A48C41F1

Q33556747-5EE031E3-0F31-4D59-9B8B-AD4F31D69FDF

Q33556747-66BBEA63-9508-43A5-9FEA-2490D6BCAE11

P304

Q33556747-D5A2C97F-371E-4668-A966-A8B72471D27A

P31

Q33556747-9B275316-B441-4587-9B99-AD67FA161451

P356

Q33556747-823D27A4-E533-4525-A832-890148A69D70

P407

Q33556747-203A90D2-680F-4E67-B674-72B706E36C53

P433

Q33556747-182A4446-F89F-4D43-B104-3FAB2CB55A67

P478

Q33556747-4549D197-EC0D-4F67-AA5F-23EFAE35146C

P577

Q33556747-31ACBC8E-E943-472F-A5F8-1DC6C7B7E3C5

P5875

Q33556747-171B52E2-84D2-4A35-B0CC-1BC13DE2B617

P698

Q33556747-E1AC067C-5266-4CA0-86BE-81052D97D415

P921

Q33556747-D06C95A7-9C2D-45DC-87C8-FABF015D2031

P932

Q33556747-5873A566-E170-424D-AC52-C21F05DBDDE6

P356

P1433

P1476

Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.

@en

P2093

Feng Wang

http://www.w3.org/2001/XMLSchema#string

Jiamei Jiang

http://www.w3.org/2001/XMLSchema#string

Lifang Li

http://www.w3.org/2001/XMLSchema#string

Limei Liu

http://www.w3.org/2001/XMLSchema#string

Ming Li

http://www.w3.org/2001/XMLSchema#string

Niansong Wang

http://www.w3.org/2001/XMLSchema#string

Taishan Zheng

http://www.w3.org/2001/XMLSchema#string

Weijing Zhao

http://www.w3.org/2001/XMLSchema#string

Yanyan Song

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

The peroxisome proliferator-activated receptor-gamma2 Pro12Ala polymorphism

Oxidative stress as a major culprit in kidney disease in diabetes

Diabetic nephropathy: diagnosis, prevention, and treatment.

Insulin resistance in diabetic nephropathy--cause or consequence?

Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.

Oxidative stress and accelerated vascular aging: implications for cigarette smoking.

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

P304

144-149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-1258

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38018948

http://www.w3.org/2001/XMLSchema#string

P698

19837787

http://www.w3.org/2001/XMLSchema#string

P921

P932

2797960

http://www.w3.org/2001/XMLSchema#string